Form 4: Predictive Oncology Director Daniel E. Handley Reports Share Acquisition and Disposal
SEC Form 4 Filing
Director Daniel E. Handley reports acquiring and disposing of shares of Predictive Oncology Inc. on April 5, 2024.
Summary
- On April 5, 2024, Daniel E. Handley, a director of Predictive Oncology Inc., reported a transaction involving the company's common stock.
- Handley acquired 2,353 shares and disposed of 18,661 shares.
- Following the transaction, Handley still beneficially owns an unspecified amount of common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders and provides transparency into their trading activities.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Date of the stock transaction (acquisition and disposal). |
| 04/12/2024 | Date of signature for the report. |
Keywords
Form 4, Predictive Oncology Inc., POAI, Daniel E. Handley, Director, Beneficial Ownership, Stock Transaction, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.